SEC Form 4 · accession 0001140361-15-010221
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil K Warma
Officer — President & CEO · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.82 | Mar 2, 2015 | A | 120,000 | A | — | Mar 2, 2025 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F125% vests on the one-year anniversary of the date of grant and the balance vests quarterly over the remaining three years.